The Role of Multislice Computed Tomography in Congenital Heart Diseases in Paediatric Age Group.

NCT ID: NCT06223321

Last Updated: 2024-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-03

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the added value of cardiac multislice Computed Tomography in assessment of CHD in pediatrics as a non-invasive presurgical planning method

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients will be subjected to the followings:

* All children gave an informed consent prior performing the research.
* Every child was submitted to full history taking.
* Clinical assessment of the patients will be performed in the form of: measuring of vital signs and anthropometric measurements.
* Renal function tests(ѕerum creatinine and blood urea).
* Patients will be prepared for CT as following:

* Calculation of amount of CM and sedations.
* The patient will be fasting for 4 hours.
* The peripheral venous line will placed usually in a right upper limb vein, exercise if cosurgical .
* The patients will be put in a supine position and at the middle of CT gantry.
* ECG leads will be put on the chest of the patient. Infants below 6 months will be laid with arms at their side or above their head for image acquisition, positioning the arms above their head is advised, while patients above 6 months of age were positioned with their arms above their head when possible.
* CT examination will be done by

* 160 MDCT Toshiba Machine or 128 MDCT GE machine or 160 MDCT Philips Machine:
* We used the following parameters during cardiac CT scanning:

* Pitch of 1.3, helical thickness of 0.5 mm and coverage of 32 cm.
* The radiation dose set to 80-100 kvp.
* Tube current from 10 to 40 mA/kg.
* The gantry rotation speed at 0.35-.4 sec.
* ECG gated Retrospective With MA modulation.
* Wide FOV.
* A scout will be taken and dual-phase injection conducted using non ionized contrast material. The total contrast volume is 1.5-3 ml/kg.
* Scanning begins when contrast filled the LV by bolus tracking.
* All images were transferred to workstation multiplanar reformation (MPR), maximum (MIP) and minimum (MinIP) intensity projections and volume rendering images will be performed for reporting.
* Reporting in sequential approach

* Cardiac sidedness
* Cardiac position
* Three segments , atrial chambers , ventricular chambers and the great arteries (aorta and pulmonary arteries)
* Cardiac connections (veno-atrial ,atrio-ventricular and ventriculo-arterial )
* Associated malformation (intra cardiac communications , valvular pathologies)
* Aortic arch and its branching pattern
* Pulmonary arteries
* Pulmonary veins (number and drainage pattern )
* SVC,IVC (their course and draining pattern )
* Systematic veins azygos , hemiazygos and brachiocephalic vein
* Coronary arteries
* Position of abdominal organs( liver spleen, stomach \& pancrease )
* Secondary changes in cardiac chambers and lung parenchyma
* Bony anomalies
* Results: Results will be tabulated and assessed statistically and compared to other published results.
* Ethical consideration and Study approval: The study protocol will be approved by the ethics committee of Faculty of Medicine, Sohag University.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Computed Tomography in congenital heart diseases

● CT examination will be done by

* 160 MDCT Toshiba Machine or 128 MDCT GE machine or 160 MDCT Philips Machine:
* We used the following parameters during cardiac CT scanning:

* Pitch of 1.3, helical thickness of 0.5 mm and coverage of 32 cm.
* The radiation dose set to 80-100 kvp.
* Tube current from 10 to 40 mA/kg.
* The gantry rotation speed at 0.35-.4 sec.
* ECG gated Retrospective With MA modulation.
* Wide FOV.
* A scout will be taken and dual-phase injection conducted using non ionized contrast material. The total contrast volume is 1.5-3 ml/kg.
* Scanning begins when contrast filled the LV by bolus tracking.
* All images were transferred to workstation multiplanar reformation (MPR), maximum (MIP) and minimum (MinIP) intensity projections and volume rendering images will be performed for reporting.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients suspected to have congenital heart disease based on clinical findings.
2. Patients known to have congenital heart diseased based on echocardiography (ECHO) with ECHO findings are not sufficient and referred to perform CT for further assessment

Exclusion Criteria

* Post-operative Patients of congenital heart disease.
* Patients who are known to have hyper susceptibility to iodinated Contrast media reaction, impaired renal functions, respiratory failure, fever and severe asthma and patients with arrhythmia.
Minimum Eligible Age

1 Day

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Magdi Yacoub Heart Foundation

OTHER

Sponsor Role collaborator

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Ahmed Abdelghany Elsherif

ASSISTANT LECTURE AT DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY DEPARTMENT

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed AA Elsherif, ASSISST. LEC

Role: PRINCIPAL_INVESTIGATOR

Sohag University Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag university hospitals- faculity of medicine

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-23-12-02MD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Role of CT in Tetralogy of Fallot Diagnosis
NCT07247435 NOT_YET_RECRUITING